Quick Answer
enVVeno Medical Corp reported Operating Income Loss of -$20.90 million for the year ending 2025.
- enVVeno Medical Corp showed an increase of +12.3% in Operating Income Loss from 2024 to 2025.
- This data is from enVVeno Medical Corp's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), enVVeno Medical Corp's Operating Income Loss has declined by 242.4%.
- Historical annual values: Fiscal year 2025: -$20.90 million | Fiscal year 2024: -$23.83 million | Fiscal year 2023: -$25.24 million | Fiscal year 2022: -$24.93 million | Fiscal year 2021: -$16.89 million | Fiscal year 2020: -$9.14 million | Fiscal year 2019: -$7.68 million | Fiscal year 2018: -$7.85 million | Fiscal year 2017: -$6.10 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: